Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GENTEX CORPGNTX · Entity 3954 | General Counsel | February 17, 2026 | February 19, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GENTEX CORP
Report date February 17, 2026 · Filed February 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 67,702 |
Reported balance
After 2026-02-17 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-02-17 · Grant · Acquired 25,782 · Balance 67,702 F1: 25,782 shares are performance-based shares where the total number of shares granted were based on long term performance incentives. F2: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan |
| Common StockSEC Table I · non-derivative | Direct | 56,210 |
Reported balance
After 2026-02-17 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-02-17 · Tax withholding · Disposed 11,492 · Balance 56,210 |
| Common StockSEC Table I · non-derivative | Direct | 53,303 |
Reported balance
After 2026-02-17 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2026-02-17 · Tax withholding · Disposed 2,907 · Balance 53,303 |
| Common StockSEC Table I · non-derivative | Direct | 46,158 |
Reported balance
After 2026-02-17 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2026-02-17 · Sale · Disposed 7,145 · Balance 46,158 |
| Common StockSEC Table I · non-derivative | Direct | 44,279 |
Reported balance
After 2026-02-17 transaction · row 5
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 5 · 2026-02-17 · Sale · Disposed 1,879 · Balance 44,279 |
| Common StockSEC Table I · non-derivative | Direct | 55,279 |
Reported balance
After 2026-02-19 transaction · row 6
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 6 · 2026-02-19 · Grant · Acquired 11,000 · Balance 55,279 F3: These shares vest 100% three years from grant award date. |
Filing footnotes · ownership attribution and instrument terms
F1: 25,782 shares are performance-based shares where the total number of shares granted were based on long term performance incentives.
F2: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan
F3: These shares vest 100% three years from grant award date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 20, 2019 Filed Feb 22, 2019 22:16 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 4,958 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-19-001282 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,608 F1 · shares: These shares vest 100% three years from grant award date. F2 · price: Shares granted under the Gentex Corporation 2019 Omnibus Incentive Plan, which is a Rule 16B-3 Plan; pending shareholder approval. Read SEC document |
| December 30, 2018 Filed Dec 31, 2018 19:25 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 3,000 | $19.88 | $59,640.00 |
DisclosureSEC source: 0001562180-18-005126 · primarydocument.xml · nonDerivative · entry 2 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,513 F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| December 28, 2018 Filed Dec 31, 2018 19:25 UTC | GENTEX CORP GNTX · Entity 3954 | PurchaseCommon Stock | 148 | $16.86 | $2,495.28 |
DisclosureSEC source: 0001562180-18-005126 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,513 F1 · kind: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan Read SEC document |
| September 28, 2018 Filed Jan 16, 2019 19:57 UTC | GENTEX CORP GNTX · Entity 3954 | PurchaseCommon Stock | 137 | $18.24 | $2,498.88 |
DisclosureSEC source: 0001562180-19-000311 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,650 F1 · kind: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan Read SEC document |
| June 29, 2018 Filed Jul 3, 2018 00:26 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 128 | $19.57 | $2,504.96 |
DisclosureSEC source: 0001562180-18-003181 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,365 F1 · price: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan Read SEC document |
| March 29, 2018 Filed Apr 2, 2018 22:17 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 128 | $19.57 | $2,504.96 |
DisclosureSEC source: 0001562180-18-001775 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,237 F1 · price: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 18:52 UTC | GENTEX CORP GNTX · Entity 3954 | GrantEmployee Stock Option (Right to buy) · Derivative | 25,000 | $22.94 Strike: $22.94 | $573,500.00 |
DisclosureSEC source: 0001562180-18-001068 · primarydocument.xml · derivative · entry 2 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2028-02-15 F3 · price: Options granted under the Gentex Corporation Employee Stock Option Plan, which is a Rule 16B-3 Plan. F4 · derivative.exercise_date: These shares become exercisable as to 25% one year after date of grant and an additional 25% at each ensuing anniversary date. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 18:52 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-18-001068 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,109 F1 · shares: These shares vest 100% four years from grant award date. F2 · price: Shares granted under the Gentex Corporation Restricted Stock Plan, which is a Rule 16B-3 Plan. Read SEC document |
| January 31, 2018 Filed Feb 1, 2018 16:19 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionEmployee Stock Option (Right to buy) · Derivative | 7,220 | $16.42 Strike: $16.42 | $118,516.30 |
DisclosureSEC source: 0001562180-18-000506 · primarydocument.xml · derivative · entry 3 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,220 shares Expires 2018-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These shares become exercisable as to 25% one year after date of grant and an additional 25% at each ensuing anniversary date. Read SEC document |
| January 31, 2018 Filed Feb 1, 2018 16:19 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 7,220 | $23.66 | $170,823.03 |
DisclosureSEC source: 0001562180-18-000506 · primarydocument.xml · nonDerivative · entry 2 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,109 F1 · price: This transaction was executed in multiple trades at prices ranging from $23.62 to $23.69. The price reported above reflects the weighted average price. Read SEC document |
| January 31, 2018 Filed Feb 1, 2018 16:19 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionCommon Stock | 7,220 | $16.42 | $118,516.30 |
DisclosureSEC source: 0001562180-18-000506 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,329 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 29, 2017 Filed Jan 2, 2018 17:17 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 140 | $17.81 | $2,493.40 |
DisclosureSEC source: 0001562180-18-000036 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,109 F1 · shares: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan Read SEC document |
| September 29, 2017 Filed Oct 3, 2017 18:25 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 148 | $16.83 | $2,490.84 |
DisclosureSEC source: 0001562180-17-003145 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,969 F1 · price: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 16:29 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 156 | $16.12 | $2,514.72 |
DisclosureSEC source: 0001562180-17-002366 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,821 F1 · price: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan Read SEC document |
| April 24, 2017 Filed Apr 25, 2017 12:35 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionEmployee Stock Option (Right to buy) · Derivative | 4,920 | $9.38 Strike: $9.38 | $46,125.00 |
DisclosureSEC source: 0001562180-17-001539 · primarydocument.xml · derivative · entry 3 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,920 shares Expires 2017-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2017 Filed Apr 25, 2017 12:35 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 4,920 | $20.38 | $100,259.27 |
DisclosureSEC source: 0001562180-17-001539 · primarydocument.xml · nonDerivative · entry 2 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,665 Read SEC document |
| April 24, 2017 Filed Apr 25, 2017 12:35 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionCommon Stock | 4,920 | $9.38 | $46,125.00 |
DisclosureSEC source: 0001562180-17-001539 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,585 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 12:58 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 689 | $18.13 | $12,491.57 |
DisclosureSEC source: 0001562180-17-001393 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,665 F1 · price: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan Read SEC document |
| February 16, 2017 Filed Feb 21, 2017 17:46 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 1,512 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-17-000817 · primarydocument.xml · nonDerivative · entry 2 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,976 F3 · shares: These shares vest 100% four years from grant award date. F2 · price: Shares granted under the Gentex Corporation Restricted Stock Plan, which is a Rule 16B-3 Plan. Read SEC document |
| February 16, 2017 Filed Feb 21, 2017 17:46 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 1,820 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-17-000817 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,464 F1 · shares: These shares vest 100% five years from grant award date. F2 · price: Shares granted under the Gentex Corporation Restricted Stock Plan, which is a Rule 16B-3 Plan. Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 15:25 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 149 | $16.74 | $2,494.26 |
DisclosureSEC source: 0001562180-17-000099 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,644 F1 · price: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 16:05 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 181 | $14.93 | $2,702.33 |
DisclosureSEC source: 0001562180-16-003197 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,495 F1 · price: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.